Order Entry
United Kingdom
ContactUsLinkComponent
Azeliragon (TTP488) is an orally bioavailable inhibitor of the receptor for advanced glycation end products (RAGE) in development as a potential treatment to slow disease progression in patients with mild Alzheimer’s disease (AD)[1]. Azeliragon also 1 * 100 mg
Catalog # MDEXHY-50682
Supplier:  MEDCHEMEXPRESS
Azeliragon (TTP488) is an orally bioavailable inhibitor of the receptor for advanced glycation end products (RAGE) in development as a potential treatment to slow disease progression in patients with mild Alzheimer’s disease (AD)[1]. Azeliragon also 1 * 100 mg
Catalog # MDEXHY-50682
Supplier:  MEDCHEMEXPRESS
Frequently Bought Together